LIN9 is a mitotic vulnerability in triple-negative breast cancer that is targetable with BET inhibitors.

被引：0
|
作者：
Sahni, J. M. [1 ]
Gayle, S. S. [1 ]
Webb, B. M. [1 ]
Weber-Bonk, K. L. [1 ]
Singh, S. [2 ]
Sizemore, S. T. [3 ]
Bebek, G. [4 ]
Varadan, V. [2 ]
Summers, M. K. [3 ]
Keri, R. A. [1 ,5 ,6 ]
机构：
[1] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
[3] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA
[4] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA
[6] Case Western Reserve Univ, Dept Gen Med Sci Oncol, Cleveland, OH 44106 USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P1270
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors
    Sahni, Jennifer M.
    Gayle, Sylvia S.
    Webb, Bryan M.
    Weber-Bonk, Kristen L.
    Seachrist, Darcie D.
    Singh, Salendra
    Sizemore, Steven T.
    Restrepo, Nicole A.
    Bebek, Gurkan
    Scacheri, Peter C.
    Varadan, Vinay
    Summers, Matthew K.
    Keri, Ruth A.
    CANCER RESEARCH, 2017, 77 (19) : 5395 - 5408
  • [2] BET Bromodomain Inhibitors in Triple-Negative Breast Cancer
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (04) : 343 - 343
  • [3] LIN9 regulation of NEK2 underlies taxol resistance in triple-negative breast cancer
    Shively, M. S.
    Gayle, S. S.
    Sahni, J. M.
    Keri, R. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [4] LIN9 regulation of NEK2 underlies taxol resistance in triple-negative breast cancer
    Shively, Melyssa S.
    Keri, Ruth A.
    CANCER RESEARCH, 2019, 79 (13)
  • [5] LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP
    Hongna Lai
    Rui Wang
    Shunying Li
    Qianfeng Shi
    Zijie Cai
    Yudong Li
    Yujie Liu
    Science China Life Sciences, 2020, 63 : 419 - 428
  • [6] LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP
    Lai, Hongna
    Wang, Rui
    Li, Shunying
    Shi, Qianfeng
    Cai, Zijie
    Li, Yudong
    Liu, Yujie
    SCIENCE CHINA-LIFE SCIENCES, 2020, 63 (03) : 419 - 428
  • [7] LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP
    Hongna Lai
    Rui Wang
    Shunying Li
    Qianfeng Shi
    Zijie Cai
    Yudong Li
    Yujie Liu
    Science China(Life Sciences), 2020, 63 (03) : 419 - 428
  • [8] Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
    Shu, Shaokun
    Lin, Charles Y.
    He, Housheng Hansen
    Witwicki, Robert M.
    Tabassum, Doris P.
    Roberts, Justin M.
    Janiszewska, Michalina
    Huh, Sung Jin
    Liang, Yi
    Ryan, Jeremy
    Doherty, Ernest
    Mohammed, Hisham
    Guo, Hao
    Stover, Daniel G.
    Ekram, Muhammad B.
    Peluffo, Guillermo
    Brown, Jonathan
    D'Santos, Clive
    Krop, Ian E.
    Dillon, Deborah
    McKeown, Michael
    Ott, Christopher
    Qi, Jun
    Ni, Min
    Rao, Prakash K.
    Duarte, Melissa
    Wu, Shwu-Yuan
    Chiang, Cheng-Ming
    Anders, Lars
    Young, Richard A.
    Winer, Eric P.
    Letai, Antony
    Barry, William T.
    Carroll, Jason S.
    Long, Henry W.
    Brown, Myles
    Liu, X. Shirley
    Meyer, Clifford A.
    Bradner, James E.
    Polyak, Kornelia
    NATURE, 2016, 529 (7586) : 413 - +
  • [9] Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
    Shaokun Shu
    Charles Y. Lin
    Housheng Hansen He
    Robert M. Witwicki
    Doris P. Tabassum
    Justin M. Roberts
    Michalina Janiszewska
    Sung Jin Huh
    Yi Liang
    Jeremy Ryan
    Ernest Doherty
    Hisham Mohammed
    Hao Guo
    Daniel G. Stover
    Muhammad B. Ekram
    Guillermo Peluffo
    Jonathan Brown
    Clive D’Santos
    Ian E. Krop
    Deborah Dillon
    Michael McKeown
    Christopher Ott
    Jun Qi
    Min Ni
    Prakash K. Rao
    Melissa Duarte
    Shwu-Yuan Wu
    Cheng-Ming Chiang
    Lars Anders
    Richard A. Young
    Eric P. Winer
    Antony Letai
    William T. Barry
    Jason S. Carroll
    Henry W. Long
    Myles Brown
    X. Shirley Liu
    Clifford A. Meyer
    James E. Bradner
    Kornelia Polyak
    Nature, 2016, 529 : 413 - 417
  • [10] LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP
    Hongna Lai
    Rui Wang
    Shunying Li
    Qianfeng Shi
    Zijie Cai
    Yudong Li
    Yujie Liu
    Science China(Life Sciences), 2020, (03) : 419 - 428
12345